Circulating neonatal Nav1.5 (nNav1.5) antigen and anti-nNav1.5 antibodies as potential biomarkers for breast cancer metastasis
Neonatal Nav1.5 (nNav1.5) has been known to potentiate breast cancer (BCa) metastasis. The detection of anti-nNav1.5 antibodies (anti-nNav1.5-Ab) reflects the immunogenicity of nNav1.5. However, the presences of circulating nNav1.5 antigen and anti-nNav1.5-Ab in the context of BCa metastasis hav...
Main Authors: | Harishini Rajaratinam, Nur Syahmina Rasudin, Maya Mazuwin Yahya, Wan Zainira Wan Zain, Sabreena Safuan, Nurul Asma-Abdullah, Noor Fatmawati Mokhtar, Wan Ezumi Mohd Fuad |
---|---|
Format: | Article |
Language: | English |
Published: |
Penerbit Universiti Kebangsaan Malaysia
2022
|
Online Access: | http://journalarticle.ukm.my/20650/1/18.pdf |
Similar Items
-
The role of REST and HDAC2
in epigenetic dysregulation of Nav1.5
and nNav1.5 expression in breast cancer
by: Kamarulzaman, Nur Sabrina, et al.
Published: (2017) -
The roles of circulating neonatal
nav1.5 (NNAV1.5) and its antibodies in
cancer progression of 4T1 orthotopic
mice model and breast cancer
patients
by: Rajaratinam, Harishini A/P
Published: (2023) -
Development of orthotopic breast cancer and detection of nNav 1.5 serum antibody in syngeneic mouse model
by: Noor, Aina Akmal Mohd
Published: (2019) -
Evaluation of anti-nNav1.5 antibodies
as potential therapeutic agent in
suppressing breast cancer invasion
and metastasis
by: Sharudin, Nur Aishah
Published: (2022) -
Discovering the Triad between Nav1.5, Breast Cancer, and the Immune System: A Fundamental Review and Future Perspectives
by: Harishini Rajaratinam, et al.
Published: (2022-02-01)